{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "TiadyLT ER is a prescription medication containing diltiazem hydrochloride, a calcium channel blocker that helps relax blood vessels and improve blood flow to the heart. It's used to treat high blood pressure, chest pain (angina), and certain heart rhythm problems. Available as extended-release oral capsules in strengths from 120mg to 420mg, manufactured by Zydus Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Diltiazem hydrochloride \u2014 ANDA 075116 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075116", "mediaType": "text/html", "title": "Diltiazem hydrochloride"}], "identifier": "ANDA075116", "issued": "2016-09-16", "keyword": ["public-health", "drug-safety", "prescription-drugs", "drug", "drug-information"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Diltiazem hydrochloride"}